Here's the live share price of Biocon along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Biocon has declined 0.54% CAGR. Over the past year, the corresponding return has been 19.23%.
Biocon’s current P/E of 103.29x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Biocon | -1.40 | 1.91 | -1.42 | 7.41 | 19.23 | 20.83 | -0.54 |
| Sun Pharmaceutical Industries | 0.09 | 6.03 | 0.18 | 12.36 | 6.93 | 23.57 | 24.36 |
| Divi's Laboratories | -4.15 | -1.69 | -4.44 | 0.21 | 7.92 | 29.88 | 12.20 |
| Torrent Pharmaceuticals | 1.83 | 7.68 | 16.02 | 24.20 | 43.43 | 42.77 | 29.25 |
| Dr. Reddy's Laboratories | -1.19 | 1.64 | 0.62 | -0.96 | 16.30 | 13.69 | 8.21 |
| Cipla | -0.58 | -1.26 | -12.81 | -15.10 | -10.09 | 14.51 | 10.29 |
| Lupin | -1.26 | 5.26 | 10.75 | 13.09 | 17.56 | 52.37 | 16.88 |
| Zydus Lifesciences | -0.80 | 0.09 | -1.69 | -12.64 | 2.62 | 24.84 | 15.54 |
| Mankind Pharma | -2.23 | 3.75 | -0.24 | -17.26 | -2.88 | 14.50 | 8.46 |
| Aurobindo Pharma | 5.25 | 12.86 | 9.34 | 17.98 | 18.41 | 42.46 | 9.20 |
| Alkem Laboratories | -3.51 | -1.04 | -4.83 | -2.81 | 13.63 | 20.32 | 14.77 |
| Glenmark Pharmaceuticals | 2.46 | 8.91 | 9.52 | 3.59 | 54.84 | 72.23 | 35.65 |
| Abbott India | -1.40 | 1.86 | -3.34 | -12.81 | -8.94 | 10.09 | 13.16 |
| Laurus Labs | -2.29 | -0.81 | -0.23 | 12.08 | 74.73 | 48.84 | 22.92 |
| GlaxoSmithKline Pharmaceuticals | -3.55 | -6.57 | -5.88 | -12.03 | -8.80 | 23.18 | 11.12 |
| Ipca Laboratories | 4.71 | 4.85 | 8.28 | 19.13 | 20.20 | 25.38 | 10.22 |
| Ajanta Pharma | 1.04 | 3.53 | 14.51 | 18.53 | 18.92 | 35.33 | 19.95 |
| Anthem Biosciences | -3.18 | -7.08 | -8.42 | -23.33 | -12.37 | -4.31 | -2.61 |
| J B Chemicals & Pharmaceuticals | 3.44 | 12.10 | 18.39 | 26.38 | 39.78 | 29.55 | 28.72 |
| Emcure Pharmaceuticals | 1.46 | -3.57 | 2.79 | 6.16 | 54.96 | 1.85 | 1.10 |
Over the last one year, Biocon has gained 19.23% compared to peers like Sun Pharmaceutical Industries (6.93%), Divi's Laboratories (7.92%), Torrent Pharmaceuticals (43.43%). From a 5 year perspective, Biocon has underperformed peers relative to Sun Pharmaceutical Industries (24.36%) and Divi's Laboratories (12.20%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 391.57 | 392.42 |
| 10 | 390.39 | 390.41 |
| 20 | 385.78 | 386.85 |
| 50 | 379.59 | 383 |
| 100 | 383.83 | 379.85 |
| 200 | 372.06 | 372.11 |
In the latest quarter, Biocon saw a drop in promoter holding to 44.92%, while DII stake increased to 24.16%, FII holding rose to 7.14%, and public shareholding moved down to 23.69% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 4,00,73,925 | 3.02 | 1,469.91 | |
| 1,55,98,584 | 2.55 | 572.16 | |
| 1,30,00,000 | 1.59 | 476.84 | |
| 1,20,44,737 | 1.18 | 441.8 | |
| 1,02,45,640 | 0.93 | 375.81 | |
| 97,73,314 | 1.56 | 358.49 | |
| 69,86,253 | 1.11 | 256.26 | |
| 60,45,476 | 1.47 | 228.49 | |
| 60,26,895 | 0.45 | 221.07 | |
| 58,06,295 | 2.51 | 212.97 |
* Excluding Index & Arbitrage Funds
| Price | (%) As on Invalid Date IST |
| Open Interest | (%) |
| High | |
| Low | |
| Open | |
| Close | |
| Contract Traded | |
| Turnover (in lakhs) |
Date Time | Announcement |
|---|---|
| Mar 13, 2026, 2:40 AM IST | Biocon - Notification To Stock Exchanges |
| Mar 05, 2026, 9:21 PM IST | Biocon - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Mar 04, 2026, 4:35 AM IST | Biocon - Announcement under Regulation 30 (LODR)-Acquisition |
| Mar 02, 2026, 10:23 PM IST | Biocon - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Feb 25, 2026, 12:07 PM IST | Biocon - Announcement under Regulation 30 (LODR)-Investor Presentation |
Biocon Ltd. is a Public Limited Listed company incorporated on 29/11/1978 and has its registered office in the State of Karnataka, India. Company's Corporate Identification Number(CIN) is L24234KA1978PLC003417 and registration number is 003417. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 2242.60 Cr. and Equity Capital is Rs. 600.30 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Biocon is ₹385.00 as on Mar 13, 2026.
The Biocon is operating in the Pharmaceuticals and health care Sector. It is classified as a Largecap stock on the BSE.
The market cap of Biocon is ₹62,404.95 Cr as on Mar 13, 2026.
Today’s highest and lowest price of Biocon are ₹398.65 and ₹382.35.
The 52-week high/low is the highest and lowest price at which Biocon stock has traded in the past 52-week or nearly a year. The 52-week high of Biocon is ₹424.95 and 52-week low of Biocon is ₹295.30 as on Mar 13, 2026.
The Biocon has shown returns of -1.96% over the past day, 1.91% for the past month, -1.42% over 3 months, 19.23% over 1 year, 20.83% across 3 years, and -0.54% over 5 years.
P/E ratio of and PB ratio of Biocon are 103.29 and 2.32 on Mar 13, 2026. While the company gives a dividend yield of 0.13 per annum.